Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05867316 · ClinicalTrials.gov registry record · NA
Supplementing Brief Psychotherapy With a Mobile App
A NA study of Emotion Regulation and Suicide and Self-harm, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05867316: Completed NA study of Emotion Regulation and Suicide and Self-harm, sponsored by Rutgers, The State University of New Jersey.
NCT05867316 is a NA study of Emotion Regulation and Suicide and Self-harm that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 40 participants, below the 200-participant average among 25 other Emotion Regulation trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05867316, a NA study of Emotion Regulation and Suicide and Self-harm, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Suicide is among the leading causes of death worldwide, and the risk of suicide is highest in the period immediately following discharge from inpatient psychiatric care.1Importantly, despite the enormously elevated risk during this period, nearly 50% of patients do not attend scheduled therapy after discharge. Even among those who do attend therapy, however, the skills learned in treatment may be difficult to use during the highly distressing time leading up to and during a suicide crisis. Most traditional treatments are not designed to be effective during a suicide crisis. In order to reduce the risk of suicidal thoughts and behaviors in general and specifically during the post-discharge period, interventions are needed that: (1) are easily adhered to and (2) are accessible and effective during a suicide crisis. As such, the purpose of this research study is to test an innovative, new intervention in order to develop an effective and accessible intervention for those at high risk for suicide
Primary Outcome
This is an 11-point scale regarding momentary self-reported intensity of suicidal urges ("Right now, how strongly do you want to kill yourself?". A score of 0 is equivalent to no suicidal thinking at all ("not at all"), a score of 10 is a score of very extreme suicidal thinking ("Extremely). Lower scores equal less severe suicidal thinking (i.e., a better outcome). Scores are averaged across all participants and all instances of survey completion.
Conditions Studied
Interventions
- BEHAVIORAL Unified Protocol
Study Locations (1)
New Jersey
- Rutgers University Behavioral Healthcare - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-09-14 |
| Est. Completion | 2024-06-06 |
| Phase | NA |
What the finished NCT05867316 record still lists
NCT05867316 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 200-participant average among 25 other Emotion Regulation trials with a reported enrollment target (80% lower).
The record links to 2 conditions, with Emotion Regulation appearing as the primary indexed condition, and to 1 intervention - of which Unified Protocol is the first listed.
NCT05867316 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT05867316 about?
NCT05867316 is a clinical study titled "Supplementing Brief Psychotherapy With a Mobile App". Suicide is among the leading causes of death worldwide, and the risk of suicide is highest in the period immediately following discharge from inpatient psychiatric care.1Importantly, despite the enormously elevated risk during this period, nearly 50% of patients do not attend scheduled therapy after...
What is the current status of trial NCT05867316?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-09-14. Estimated completion is 2024-06-06.
What conditions does trial NCT05867316 study?
This clinical trial studies the following conditions: Emotion Regulation, Suicide and Self-harm.
What interventions are being tested in trial NCT05867316?
The interventions under investigation include: Unified Protocol (BEHAVIORAL).
Who is sponsoring clinical trial NCT05867316?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05867316 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emotion Regulation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05867316's enrollment target sits among peer trials
40 25th of 25 higher than 1 of 25 other Emotion Regulation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Emotion Regulation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
LH Canine Therapy Study
RECRUITING · NA
-
Community-based Implementation of Online EmReg
RECRUITING · NA
-
Feasibility of a Dog Training Therapy Program in UC Outpatient Youth Receiving Psychiatric Services
RECRUITING · NA
-
SCREENS: Sleep, Circadian Rhythms, and Electronics in the EveNing Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI